Allergenis to present at Biotech Showcase
CEO will present progress throughout 2022 and outlook for 2023
Hatfield, PA - January 3, 2023
Allergenis, a commercial stage biotechnology company which aims to revolutionize the diagnosis and management of food allergy, today announced it is presenting at the upcoming Biotech Showcase™ 2023 conference, coinciding with the 41st Annual J.P. Morgan Health Care Conference in San Francisco, January 9-12, 2023.
Jim Garner, chief executive officer, is scheduled to present Tuesday, January 10th at 2:45 p.m. Pacific Time / 5:45 p.m. Eastern Time. During the presentation, Garner will highlight Allergenis’ experienced leadership team and recent corporate achievements.
“We are looking forward to meeting with current and potential investors at the Biotech Showcase,” commented Garner. “The conference provides a great opportunity to provide in-person updates demonstrating our progress towards revolutionizing the diagnosis and management of food allergy.”
Using its proprietary epitope mapping platform, Allergenis is developing products which enable routine, safe (noninvasive), reproducible, and accurate diagnosis and assessment of food allergy status and risk stratification across the continuum of care. Allergenis' blood-based test for diagnosing peanut allergies has a 93 percent concordance with an oral food challenge (OFC), the current gold standard. Unlike many available tests, which are less accurate or pose a higher risk for the patient, Allergenis' peanut allergy diagnostic leaves little area of uncertainty or indetermination.
In addition to the initial test for the diagnosis of peanut allergy, the second test in this suite provides a quantitative determination of the level of sensitivity to peanuts. Beyond peanuts, diagnostic products for other food allergens including milk, egg, and tree-nuts are in the pipeline.
“We are delighted that Allergenis will be joining us in San Francisco and presenting at Biotech Showcase this year,” said Sara Demy, CEO of Demy-Colton. “Biotech Showcase is a prime occasion for life science entrepreneurs and investors to come together to discover the potential of innovative technologies that will drive the future of health care.”
About Biotech Showcase
Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place. Investors and biopharmaceutical executives from around the world gather at Biotech Showcase during this bellwether week which sets the tone for the coming year. Now in its 15th year, this well-established, highly respected conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings. Biotech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a long history of producing high-quality programs that support the biotechnology and broader life sciences industry.
Biotech Showcase, produced by Demy-Colton and EBD Group, is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities. The conference takes place each year during the course of one of the industry's largest gatherings and busiest weeks.
About Allergenis
Allergenis is developing precision diagnostic solutions to help healthcare providers and patients better understand and manage their food allergies. Specializing in immunology and bioinformatics, they created a machine learning and AI enabled multiplexed analytical platform to address the limitations of current food allergy diagnostic tests. Allergenis provides cutting edge and highly accurate food allergy diagnostic testing, including risk stratification for children and adults. The first products for peanut allergy are in market and several additional food allergen tests including dairy, egg, and tree nuts, are in development. For more information, visit: www.allergenis.com
Contacts
Jim Garner, CEO
jim.garner@allergenis.com
Follow Allergenis on Twitter at @Allergenis and Biotech Showcase at @EBDGroup and @Demy_Colton and tag your posts with #BiotechShowcase.